We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-5.66%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$449B
AUM Growth
-$36.8B
Cap. Flow
-$692M
Cap. Flow %
-0.15%
Top 10 Hldgs %
15.79%
Holding
2,618
New
86
Increased
1,108
Reduced
800
Closed
108

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.57B
2
ELV icon
Elevance Health
ELV
+$1.16B
3
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$1.01B
4
RCL icon
Royal Caribbean
RCL
+$860M
5
AET
Aetna Inc
AET
+$790M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.76B
2
BIIB icon
Biogen
BIIB
+$1.47B
3
PCP
PRECISION CASTPARTS CORP
PCP
+$1.26B
4
MCK icon
McKesson
MCK
+$1.2B
5
SHW icon
Sherwin-Williams
SHW
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 21.75%
2 Consumer Discretionary 14.84%
3 Financials 13.9%
4 Technology 11.11%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHE icon
1901
Benchmark Electronics
BHE
$2.89B
$550K ﹤0.01%
25,275
– –
RIGL icon
1902
Rigel Pharmaceuticals
RIGL
$761M
$549K ﹤0.01%
22,245
+25
+0.1% +$746
EFOR
1903
Everforth Inc
EFOR
$1.37B
$548K ﹤0.01%
14,850
-356,160
-96% -$13.5M
BGS icon
1904
B&G Foods
BGS
$299M
$547K ﹤0.01%
15,000
– –
CMD
1905
DELISTED
Cantel Medical Corporation
CMD
$544K ﹤0.01%
9,600
– –
BGG
1906
DELISTED
Briggs & Stratton Corp.
BGG
$541K ﹤0.01%
28,000
– –
NWN icon
1907
Northwest Natural Holdings
NWN
$2.14B
$540K ﹤0.01%
11,790
– –
MDR
1908
DELISTED
McDermott International
MDR
$539K ﹤0.01%
41,750
-4,900
-11% -$67.3K
TIVO
1909
DELISTED
Tivo Inc
TIVO
$536K ﹤0.01%
51,133
– –
CLDX icon
1910
Celldex Therapeutics
CLDX
$3.34B
$535K ﹤0.01%
3,383
+111
+3% +$31.4K
AEL
1911
DELISTED
American Equity Investment Life Holding Company
AEL
$534K ﹤0.01%
22,900
– –
MYGN icon
1912
Myriad Genetics
MYGN
$303M
$532K ﹤0.01%
14,200
-10,390
-42% -$369K
NGG icon
1913
National Grid
NGG
$81.6B
$529K ﹤0.01%
7,878
-134
-2% -$8.58K
CHMT
1914
DELISTED
Chemtura Corporation
CHMT
$529K ﹤0.01%
18,500
– –
PINC
1915
DELISTED
Premier
PINC
$526K ﹤0.01%
15,300
– –
NAVG
1916
DELISTED
Navigators Group Inc
NAVG
$526K ﹤0.01%
13,500
– –
HUN icon
1917
Huntsman Corp
HUN
$1.81B
$523K ﹤0.01%
54,000
– –
UNT
1918
DELISTED
UNIT Corporation
UNT
$521K ﹤0.01%
46,300
+17,700
+62% +$301K
ASCMA
1919
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$518K ﹤0.01%
18,925
-74,400
-80% -$2.49M
WIRE
1920
DELISTED
Encore Wire Corp
WIRE
$517K ﹤0.01%
15,840
-662,287
-98% -$23.5M
ALX
1921
Alexander's
ALX
$1.4B
$516K ﹤0.01%
1,380
+300
+28% +$116K
CERS icon
1922
Cerus
CERS
$574M
$515K ﹤0.01%
113,470
+22,800
+25% +$118K
COLM icon
1923
Columbia Sportswear
COLM
$2.96B
$515K ﹤0.01%
8,762
+3,200
+58% +$200K
SBGI icon
1924
Sinclair Inc
SBGI
$1.03B
$514K ﹤0.01%
20,310
– –
TKR icon
1925
Timken Company
TKR
$9.09B
$514K ﹤0.01%
18,700
-2,300
-11% -$73.3K
75 76
77
78 79

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates's Q3 2015 Portfolio in Review

As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
  • T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
  • T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
  • T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
  • T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
  • T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.

Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.